CIDOMYCIN ADULT
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
28-03-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
GENTAMICIN SULFATE
Available from:
Sanofi-Aventis Ireland Limited
Dosage:
80 Mg/Ml
Pharmaceutical form:
Solution for Injection
Authorization date:
2003-03-09
Summary of Product characteristics
License
Part II
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Cidomycin Adult 80 mg/2 ml Solution for injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial (2ml) contains Gentamicin Sulphate equivalent to 80 mg Gentamicin base (40mg/ml).
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Solution for injection
Clear colourless solution in a vial.
4 CLINICAL PARTICULARS
4.1 Therapeutic Indications
Gentamicin injection is indicated for the treatment of serious systemic infections including those of the central nervous
system due to organisms sensitive to this anti-infective.
4.2 Posology and method of administration
ADULTS:
Serious infections: If renal function is not impaired, 5mg/kg/daily in divided doses at six or eight hourly intervals. The
total daily dose may be subsequently increased or decreased as clinically indicated.
Systemic infections: If renal function is not impaired, 3-5mg/kg/day in divided doses according to severity of infection,
adjusting according to clinical response and body weight.
Urinary tract infections: As “Systemic infections”. Or, if renal function is not impaired, 160mg once daily may be
used.
Renal Impairment: Gentamicin is excreted by simple glomerular filtration and therefore reduce
Read the complete document
